• Aucun résultat trouvé

[PDF] Top 20 Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project

Has 10000 "Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project" found on our website. Below are the top 20 most common "Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project".

Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project

Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project

... Mantle cell lymphoma (MCL) is an incurable aggressive non-Hodgkin lymphoma (NHL), which accounts for approximately 5% of all ...most patients still experience recurrent ... Voir le document complet

20

Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL)†

Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL)†

... stratify patients into three categories, according to the presence of 0, 1 or 2 adverse ...resulted in identifying three groups of patients with a signi ficant different ... Voir le document complet

6

The REFRACT-LYMA cohort study: a French observational prospective cohort study of patients with mantle cell lymphoma.

The REFRACT-LYMA cohort study: a French observational prospective cohort study of patients with mantle cell lymphoma.

... to the gastrointestinal tract and bone mar- row ...associated with temporary response to therapy, varying from months to decades, and the high relapse rate over time results in a ... Voir le document complet

9

The REFRACT-LYMA cohort study: a French observational prospective cohort study of patients with mantle cell lymphoma

The REFRACT-LYMA cohort study: a French observational prospective cohort study of patients with mantle cell lymphoma

... to the gastrointestinal tract and bone mar- row ...associated with temporary response to therapy, varying from months to decades, and the high relapse rate over time results in a ... Voir le document complet

9

Prognostic value of (18)F-FDG PET/CT in liver transplantation for hepatocarcinoma.

Prognostic value of (18)F-FDG PET/CT in liver transplantation for hepatocarcinoma.

... Twelve patients resulted positive to PAS. The mean sCD14 level was 1045 ! 977 ...confirmed the presence of bacterial infections within 81 ! 3.2 h from enrolment in all 12 ... Voir le document complet

1

Endobronchial ultrasound and value of PET for prediction of pathological results of mediastinal hot spots in lung cancer patients.

Endobronchial ultrasound and value of PET for prediction of pathological results of mediastinal hot spots in lung cancer patients.

... included patients from many different centres, leading to a potential selection ...69 patients (65 % of the study population) were referred to the leading centre from 26 ... Voir le document complet

7

PROGNOSTIC VALUE OF POSTTREATMENT FEDG-PET IMAGING FOLLOWING COMBINED CHEMORADIATION THERAPY IN LOCALLY ADVANCED CERVICAL CANCER

PROGNOSTIC VALUE OF POSTTREATMENT FEDG-PET IMAGING FOLLOWING COMBINED CHEMORADIATION THERAPY IN LOCALLY ADVANCED CERVICAL CANCER

... selecting patients who could be offered completion ...conclusion from this finding as the small number of patients included, the retrospective nature of our study and ... Voir le document complet

26

Optimizing statistical parametric mapping analysis of 18F-FDG PET in children.

Optimizing statistical parametric mapping analysis of 18F-FDG PET in children.

... aid in diagnosing seizure onset zones in temporal as well as in extratemporal lobe epilepsy and in lesional as well as in non-lesional cases ...[5,7,12,15,16,38]. In children, ... Voir le document complet

11

Detection of bladder metabolic artifacts in (18)F-FDG PET imaging.

Detection of bladder metabolic artifacts in (18)F-FDG PET imaging.

... included in analyses of anatomical data provided by other image ...Although PET offers high sensitivity in detecting suspected malignant metabolism, 18 F-FDG uptake is not tumor-specific ... Voir le document complet

13

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study.: MRD after immunochemotherapy in mantle-cell lymphoma

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study.: MRD after immunochemotherapy in mantle-cell lymphoma

... Appendix:The authors wish to thank the following physicians for collecting samples for MRD analysis:S. Stilgenbauer, B. Coiffier, C. Gisselbrecht, P. Lederlin, R. Forstpointner, M. Hänel, R. Bouabdallah, M. ... Voir le document complet

32

Automatic Classification of FDG-PET imaging data in Disorders of Consciousness

Automatic Classification of FDG-PET imaging data in Disorders of Consciousness

... University of Liège, Liège, Belgium, 2 Coma Science Group, GIGA-research, University of Liège, Belgium, 3 GIGA-research, University of Liège, Belgium, ... Voir le document complet

1

18-F FDG-PET in the staging of lymphocyte-predominant Hodgkin's disease.

18-F FDG-PET in the staging of lymphocyte-predominant Hodgkin's disease.

... retrospectively the usefulness of 18 F-FDG-PET in the staging of 31 patients with lymphocyte-predomi- nant Hodgkin’s disease ...(LPHD). FDG-PET ... Voir le document complet

5

Utility of 18F-FDG PET with a Semi-Quantitative Index in the Detection of Sarcomatous Transformation in Patients with Neurofibromatosis Type 1

Utility of 18F-FDG PET with a Semi-Quantitative Index in the Detection of Sarcomatous Transformation in Patients with Neurofibromatosis Type 1

... 10% of all soft tissue sarcomas, and are associated with NF1 in 32 to 60% of cases ...one of the major causes of death in NF1 ...patients. The ... Voir le document complet

7

Management of Drug Resistance in Mantle Cell Lymphoma

Management of Drug Resistance in Mantle Cell Lymphoma

... Drugs With the recent use of NGS technologies for the identification of lymphoma mutational landscape, it came out that different epigenetic deregulations were associated ... Voir le document complet

26

Usefulness of F-18-FDG PET in the post-therapy surveillance of endometrial carcinoma

Usefulness of F-18-FDG PET in the post-therapy surveillance of endometrial carcinoma

... In the present study, PET had an actual treatment im- pact in 35% (9/26) of the women with confirmed recur- rent disease, either by detecting extrapelvic foci (6/9) or by ... Voir le document complet

8

Resistance to the proteasome inhibitors: Lessons from multiple myeloma and mantle cell lymphoma

Resistance to the proteasome inhibitors: Lessons from multiple myeloma and mantle cell lymphoma

... introduction in the clinics in early 2000s, the proteasome inhibitor bortezomib (BTZ) significantly improved the prognosis of patients with multiple myeloma (MM) ... Voir le document complet

32

Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab

Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab

... NSCLC patients under anti-PD-(L)1 inhibitors according to the response and survival outcomes, regardless of the number of prior therapy lines [ 19 ...recognized the importance ... Voir le document complet

15

Quantitative evaluation of Therapeutic response by FDG-PET–CT in Metastatic Breast Cancer

Quantitative evaluation of Therapeutic response by FDG-PET–CT in Metastatic Breast Cancer

... 18 FDG-PET showed interest in breast cancer management ( 7 ), for initial staging of locally advanced cancers (stages II–III) and/or inflammatory lesions ( 8 ), detection of recurrence ... Voir le document complet

11

PROGNOSTIC VALUE OF AMPS METHOD IN ALS PATIENTS

PROGNOSTIC VALUE OF AMPS METHOD IN ALS PATIENTS

... instead of the traditional paper CRFs. The system validates the data at the point of entry, raises alert queries and utilizes a central ...at the input stage ensures ... Voir le document complet

14

Description et étude d’un nouveau profil d’atteinte métabolique au PET-FDG chez des patients atteints de démence d’Alzheimer probable

Description et étude d’un nouveau profil d’atteinte métabolique au PET-FDG chez des patients atteints de démence d’Alzheimer probable

... de patients, atteints d’une démence légère ou ...des PET-scanners ont permis d’établir des cartes typiques de chaque groupe qui seront utilisées pour sélectionner un plus grand nombre de sujets dans la base ... Voir le document complet

25

Show all 10000 documents...